Clinical Trials Browser

Interventional × Small Cell Lung Carcinoma × cixutumumab × Clear all

NCT00887159 2021-01-05

A Randomized Phase II Study of Cisplatin and Etoposide in Combination With Either Hedgehog Inhibitor GDC-0449 or IGF-1R MOAB IMC-A12 for Patients With Extensive Stage

Phase 2 Completed

168 enrolled 11 charts

Small Cell Lung Carcinoma